TGA warns of ‘possible but rare’ RSV vaccines risk Product Information for Arexvy and Abrysvo has been updated to reflect a low risk of Guillain-Barre Syndrome following vaccination.
RSV vaccine approved for use in at-risk over-50s The new TGA approval allows access to the Arexvy vaccine for at-risk adults aged 50–59, expanding the previous indication.
First Arexvy safety data released The Australian-first safety data found 63% of recipients experienced no side effects in the first three days after vaccination.
Free RSV vaccination for Qld pregnant women Queensland’s expectant mothers are now eligible for a subsidised Abrysvo vaccination, as the state’s RSV cases soar to 40,000 in 2024.
RSV vaccine added to national program To ensure ‘every single infant in Australia is protected’, a $174.5 million investment will see free vaccines for pregnant people available nationwide.
Victoria subsidises RSV immunisations for babies The State Government will fund the long-acting monoclonal antibody for unprotected newborns and eligible infants next winter.
Subsidised RSV vaccines for SA infants The State Government will roll out the new program in winter next year, with subsidised vaccines for unprotected newborns and high-risk children.
‘Disappointing’: PBAC rejects national RSV vaccine push Free immunisations for infants and the elderly will not be rolled out nationwide after the committee knocked back two vaccine applications.
NSW and Qld announce free infant RSV vaccines The RACGP has welcomed the ‘game changing’ initiatives, with cases of the potentially deadly virus surging compared to previous years.
‘No time like the present’ for Queensland RSV vaccine rollout The college is urging the state to follow Western Australia’s lead with a ‘lifesaving’ immunisation program.